BACKGROUND: Family history of prostate cancer is a well-recognized risk factor. Previous linkage studies have reported a putative prostate cancer susceptibility locus at chromosome 17q21-22. SPOP (Speckle-type POZ protein) maps to the 17q21-22 candidate linkage region and is one of the most frequently mutated genes in sporadic prostate cancers. METHODS: We performed targeted next generation sequencing to analyze 2009 exons from 202 genes in a candidate linkage region on chromosome 17q21-22 using 94 unrelated familial prostate cancer cases from the University of Michigan Prostate Cancer Genetics Project (n=54) and Johns Hopkins University (n=40) including the exons and UTRs of SPOP. RESULTS: We identified a novel SPOP missense mutation (N296I) in a man with prostate cancer diagnosed at age 43. This mutation completely segregates with prostate cancer affection status among the men in this family. The N296I mutation resides within the evolutionarily conserved Bric-a-brac, Tramtrack, Broad-complex (BTB) domain, involved in recruiting targets to Cul3 for degradation. Analysis of the prostate tumor from this individual verified the presence of heterozygous N296I as well as an ERG fusion. CONCLUSIONS: We have discovered a novel mutation in SPOP that tracks with prostate cancer within a family and is predicted to be deleterious. Taken together, our results implicate SPOP as a candidate gene for hereditary prostate cancer.
BACKGROUND: Family history of prostate cancer is a well-recognized risk factor. Previous linkage studies have reported a putative prostate cancer susceptibility locus at chromosome 17q21-22. SPOP (Speckle-type POZ protein) maps to the 17q21-22 candidate linkage region and is one of the most frequently mutated genes in sporadic prostate cancers. METHODS: We performed targeted next generation sequencing to analyze 2009 exons from 202 genes in a candidate linkage region on chromosome 17q21-22 using 94 unrelated familial prostate cancer cases from the University of Michigan Prostate Cancer Genetics Project (n=54) and Johns Hopkins University (n=40) including the exons and UTRs of SPOP. RESULTS: We identified a novel SPOP missense mutation (N296I) in a man with prostate cancer diagnosed at age 43. This mutation completely segregates with prostate cancer affection status among the men in this family. The N296I mutation resides within the evolutionarily conserved Bric-a-brac, Tramtrack, Broad-complex (BTB) domain, involved in recruiting targets to Cul3 for degradation. Analysis of the prostate tumor from this individual verified the presence of heterozygous N296I as well as an ERG fusion. CONCLUSIONS: We have discovered a novel mutation in SPOP that tracks with prostate cancer within a family and is predicted to be deleterious. Taken together, our results implicate SPOP as a candidate gene for hereditary prostate cancer.
Authors: Mirjam Blattner; Daniel J Lee; Catherine O'Reilly; Kyung Park; Theresa Y MacDonald; Francesca Khani; Kevin R Turner; Ya-Lin Chiu; Peter J Wild; Igor Dolgalev; Adriana Heguy; Andrea Sboner; Sinan Ramazangolu; Haley Hieronymus; Charles Sawyers; Ashutosh K Tewari; Holger Moch; Ghil Suk Yoon; Yong Chul Known; Ove Andrén; Katja Fall; Francecsa Demichelis; Juan Miguel Mosquera; Brian D Robinson; Christopher E Barbieri; Mark A Rubin Journal: Neoplasia Date: 2014-01 Impact factor: 5.715
Authors: C Sakakura; A Hagiwara; R Yasuoka; Y Fujita; M Nakanishi; K Masuda; A Kimura; Y Nakamura; J Inazawa; T Abe; H Yamagishi Journal: Int J Cancer Date: 2000-05-20 Impact factor: 7.396
Authors: Matthew Adams; Victoria J Cookson; Julie Higgins; Heather L Martin; Darren C Tomlinson; Jacquelyn Bond; Ewan E Morrison; Sandra M Bell Journal: J Biomol Screen Date: 2013-08-27
Authors: Zhuo Chen; Celia Greenwood; William B Isaacs; William D Foulkes; Jielin Sun; Sigun L Zheng; Lynn D Condreay; Jianfeng Xu Journal: Carcinogenesis Date: 2013-02-07 Impact factor: 4.944
Authors: Chuandong Geng; Bin He; Limei Xu; Christopher E Barbieri; Vijay Kumar Eedunuri; Sue Anne Chew; Martin Zimmermann; Richard Bond; John Shou; Chao Li; Mirjam Blattner; David M Lonard; Francesca Demichelis; Cristian Coarfa; Mark A Rubin; Pengbo Zhou; Bert W O'Malley; Nicholas Mitsiades Journal: Proc Natl Acad Sci U S A Date: 2013-04-04 Impact factor: 11.205
Authors: Jennifer L Beebe-Dimmer; William B Isaacs; Kimberly A Zuhlke; Cecilia Yee; Patrick C Walsh; Sarah D Isaacs; Anna M Johnson; Charles E Ewing; Elizabeth B Humphreys; Wasim H Chowdhury; James E Montie; Kathleen A Cooney Journal: BJU Int Date: 2014-03-05 Impact factor: 5.588
Authors: M J Alvarez-Cubero; L J Martinez-Gonzalez; I Robles-Fernandez; J Martinez-Herrera; G Garcia-Rodriguez; M Pascual-Geler; J M Cozar; J A Lorente Journal: Mol Diagn Ther Date: 2017-04 Impact factor: 4.074
Authors: Rachel M Jones; Phillip E Melton; Mark Pinese; Alexander J Rea; Evan Ingley; Mandy L Ballinger; David J Wood; David M Thomas; Eric K Moses Journal: BMC Med Genet Date: 2019-05-03 Impact factor: 2.103